References
- Aydillo, T., et al., 2020. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. New England journal of medicine, 383 (26), 2586–2588.
- Bullard, J., et al., 2020. Predicting infectious SARS-CoV-2 from diagnostic samples. Clinical infectious diseases, ciaa638. doi:10.1093/cid/ciaa638.
- Cevik, M., et al., 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. The lancet microbe, 2 (1), e13–e22.
- Corman, V. M., et al., 2020a. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance, 25 (3), 2000045.
- Corman, V. M., et al., 2020b. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests. medRxiv,
- Koff, A.G., et al., 2020. Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy. Infection control and hospital epidemiology, 1–2. doi:10.1017/ice.2020.1239.
- Mina, M.J., Parker, R., and Larremore, D.B., 2020. Rethinking covid-19 test sensitivity – a strategy for containment. The new England journal of medicine, 383 (22), e120.
- Moesker, F.M., et al., 2016. Diagnostic performance of influenza viruses and RSV rapid antigen detection tests in children in tertiary care. Journal of clinical virology, 79, 12–17.
- Perera, R., et al., 2020. SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild coronavirus disease. Emerging infectious diseases, 26 (11), 2701–2704.
- Singanayagam, A., et al., 2020. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro surveillance, 25 (32), 2001483.
- Wölfel, R., et al., 2020. Virological assessment of hospitalized patients with COVID-2019. Nature, 581 (7809), 465–469.